A detailed history of Raab & Moskowitz Asset Management LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Raab & Moskowitz Asset Management LLC holds 11,000 shares of ROIV stock, worth $132,000. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,000
Holding current value
$132,000
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$10.17 - $12.5 $111,870 - $137,500
11,000 New
11,000 $126,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.45B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Raab & Moskowitz Asset Management LLC Portfolio

Follow Raab & Moskowitz Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raab & Moskowitz Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Raab & Moskowitz Asset Management LLC with notifications on news.